| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 123622-48-0 | Fmoc-5-Ava-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 185116-43-2 | Fmoc-4-Abz-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 185116-42-1 | Fmoc-3-Abz-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 339990-32-8 | β-Sheet Breaker Peptide |
≥98% | | 询价 |
| 5 | | β-Amyloid: 33-42 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 14550-79-9 | Z-ALA-VAL-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 21929-69-1 | Z-β-Ala-Gly-Gly-OH |
≥98% | | 询价 |
| 8 | 19542-54-2 | Z-VAL-VAL-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 1802425-99-5 | Milvexian(BMS-986177 JNJ-70033093) |
≥98% | | 询价 |
| 10 | 33956-61-5 | Tetranactin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 209253-80-5 | 6β-hydroxy Eplerenone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 2468015-78-1 | Lufotrelvir(PF-07304814) |
≥98% | | 询价 |
| 13 | 1908409-18-6 | DOTA Zoledronate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 41567-78-6 | Fumagilin B |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 1030846-42-4 | AS 2034178 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 1672666-82-8 | HIF-2α-IN-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 18556-27-9 | Cyclanoline |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 120191-51-7 | Streptochlorin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 52-24-4 | Thiotepa(STEPA TESPA) |
≥98% | | 询价 |
| 20 | 55-98-1 | Busulfan(Myleran,Busulfex) |
≥98% | | 询价 |
| 21 | 299-75-2 | Treosulfan(NSC-39069 Treosulphan) |
≥98% | | 询价 |
| 22 | 4079-26-9 | PD146176(NSC168807) |
≥98% | | 询价 |
| 23 | 13073-96-6 | Decloxizine HCl(UCB-1402 NSC289116) |
≥98% | | 询价 |
| 24 | 92395-36-3 | Amrubicin HCl(Calsed) |
≥98% | | 询价 |
| 25 | 478-08-0 | Lucidin(NSC 30546) |
≥98% | | 询价 |
| 26 | 572-03-2 | Pomiferin(NSC 5113) |
≥98% | | 询价 |
| 27 | 5184-64-5 | ESI-05(NSC 116966) |
≥98% | | 询价 |
| 28 | 1665-48-1 | Metaxalone(AHR438NSC170959) |
≥98% | | 询价 |
| 29 | 5854-93-3 | L-Alanosine(NSC-153353 SDX-102) |
≥98% | | 询价 |
| 30 | 1021950-26-4 | Tyrosine kinase inhibitor |
≥98% | | 询价 |
| 31 | 14907-98-3 | Brusatol(NSC 172924) |
≥98% | | 询价 |
| 32 | 1800405-30-4 | KL-1333 |
≥98% | | 询价 |
| 33 | 224047-41-0 | Brassinazole |
≥98% | | 询价 |
| 34 | 176504-36-2 | Bisindolylmaleimide I HCl |
≥98% | | 询价 |
| 35 | 2389062-09-1 | NED-3238 |
≥98% | | 询价 |
| 36 | 1804962-84-2 | CPFX4158 |
≥98% | | 询价 |
| 37 | 681492-22-8 | Delamanid(OPC-67683) |
≥98% | | 询价 |
| 38 | 1702816-75-8 | Linperlisib(YY-20394) |
≥98% | | 询价 |
| 39 | 1575491-01-8 | TP-2857 |
≥98% | | 询价 |
| 40 | 2252316-16-6 | TBAJ-587 |
≥98% | | 询价 |
| 41 | 1801253-04-2 | LSP-249 |
≥98% | | 询价 |
| 42 | 160807-49-8 | Indirubin-3′-monoxime |
≥98% | | 询价 |
| 43 | | Intepirdine HCl(SB-742457 GSK-742457 RVT-101) |
≥98% | | 询价 |
| 44 | 224624-80-0 | Miridesap |
≥98% | | 询价 |
| 45 | 461023-63-2 | Aplaviroc HCl |
≥98% | | 询价 |
| 46 | 461443-59-4 | Aplaviroc |
≥98% | | 询价 |
| 47 | 869113-09-7 | Umeclidinium bromide |
≥98% | | 询价 |
| 48 | 1187431-43-1 | Trametinib DMSO solvate |
≥98% | | 询价 |
| 49 | 465-39-4 | Resibufogenin |
≥98% | | 询价 |
| 50 | 142273-20-9 | Kenpaullone |
≥98% | | 询价 |
| 51 | 869185-85-3 | Adezmapimod(SB-203580)hydrochloride |
≥98% | | 询价 |
| 52 | 1234563-15-5 | Epetraborole R-Mandelate |
≥98% | | 询价 |
| 53 | 1234563-16-6 | Epetraborole hydrochloride |
≥98% | | 询价 |
| 54 | 885220-61-1 | Verucerfont |
≥98% | | 询价 |
| 55 | 2237942-08-2 | (rel)-MC180295 |
≥98% | | 询价 |
| 56 | 1195768-06-9 | Dabrafenib Mesylate |
≥98% | | 询价 |
| 57 | 1345982-69-5 | Iinerixibat(GSK2330672) |
≥98% | | 询价 |
| 58 | 109946-35-2 | Tautomycin |
≥98% | | 询价 |
| 59 | 101932-71-2 | Calyculin A |
≥98% | | 询价 |
| 60 | 221243-82-9 | 1-Naphthyl PP1(1-NA-PP 1) |
≥98% | | 询价 |
m.cnreagent.com